A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors

Clinical trial NCT06285097 · TERMINATED

Trial details

NCT number: NCT06285097
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms Non-small-cell Lung Cancer Melanoma Squamous Cell Carcinoma of the Head and Neck Renal Cell Carcinoma Urothelial Carcinoma Colorectal Carcinoma Ovarian Carcinoma

Start date: 2024-02-08
Primary completion: 2025-01-03
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.